Article: Targeted Genetics Receives $4.8 Million in Equity Funding From Biogen.

Targeted Genetics Corporation today announced that it has received approximately $4.8 million from the issuance of 2,515,843 shares of its common stock to Biogen, Inc. at a price of approximately $1.91 per share.

"We have enjoyed the opportunity to work in collaboration with Biogen over the last several years to advance understanding of gene delivery technology," said H. Stewart Parker, president and chief executive officer of Targeted Genetics. "This additional funding further strengthens our financial position and will be used to support Targeted Genetics' ongoing core programs and corporate operations."

Targeted Genetics and Biogen established a ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!